Moreover, this suppression of cell viability was enhanced in EMC6-overexpressing GBM cells (Figure 5a), suggesting that EMC6 can enhance the sensitivity of GBM cells to chemotherapy. This evidence concerns the gene EMC6 and glioblastoma.